Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of a MUCI Peptide and Poly-ICLC Vaccine for Triple-Negative Breast Cancer

NCT00986609 is registered in ClinicalTrials.gov with Joseph Baar, MD, PhD as lead sponsor.

NCT NCT00986609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00986609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of a MUCI Peptide and Poly-ICLC Vaccine for Triple-Negative Breast Cancer
Lead sponsor
Joseph Baar, MD, PhD
Phase
Phase 1
Overall status
Completed
Start date
August 19, 2009
Completion date
January 21, 2016
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, inflammatory breast cancer, stage i breast cancer, stage ii breast cancer, stage iiia breast cancer, stage iiib breast cancer, stage iiic breast cancer, triple-negative breast cancer